-
A651313-10mgAMG7703 is a selective and allosteric agonists of FFA2 ( GPR43 ), the receptor for short-chain fatty acids (SCFAs), acetate, and propionate. AMG7703 can be used to research for in inflammatory and metabolic.In VitroAMG7703 (phenylacetamide 1) (30
-
A651313-25mgAMG7703 is a selective and allosteric agonists of FFA2 ( GPR43 ), the receptor for short-chain fatty acids (SCFAs), acetate, and propionate. AMG7703 can be used to research for in inflammatory and metabolic.In VitroAMG7703 (phenylacetamide 1) (30
-
A651313-50mgAMG7703 is a selective and allosteric agonists of FFA2 ( GPR43 ), the receptor for short-chain fatty acids (SCFAs), acetate, and propionate. AMG7703 can be used to research for in inflammatory and metabolic.In VitroAMG7703 (phenylacetamide 1) (30
-
A651313-5mgAMG7703 is a selective and allosteric agonists of FFA2 ( GPR43 ), the receptor for short-chain fatty acids (SCFAs), acetate, and propionate. AMG7703 can be used to research for in inflammatory and metabolic.In VitroAMG7703 (phenylacetamide 1) (30
-
A656624-1mlAMG7703 is a selective and allosteric agonists of FFA2 ( GPR43 ), the receptor for short-chain fatty acids (SCFAs), acetate, and propionate. AMG7703 can be used to research for in inflammatory and metabolic.In VitroAMG7703 (phenylacetamide 1) (30
-
A649346-10mgAminoacyl tRNA synthetase-IN-1 is a bacterial aminoacyl tRNA synthetase ( aaRS ) inhibitor.Form:SolidIC50&: Target:aaRS.
-
A649346-1mgAminoacyl tRNA synthetase-IN-1 is a bacterial aminoacyl tRNA synthetase ( aaRS ) inhibitor.Form:SolidIC50&: Target:aaRS.
-
A649346-5mgAminoacyl tRNA synthetase-IN-1 is a bacterial aminoacyl tRNA synthetase ( aaRS ) inhibitor.Form:SolidIC50&: Target:aaRS.
-
A151036-100gProduct Introduction Aminoguanidine hydrochloride has been reported in a study as inhibitor of animal nitric oxide (NO)-synthase. Crystal structure of aminoguanidine hydrochloride has been investigated by Fourier and least squares method. Its
-
A151036-25gProduct Introduction Aminoguanidine hydrochloride has been reported in a study as inhibitor of animal nitric oxide (NO)-synthase. Crystal structure of aminoguanidine hydrochloride has been investigated by Fourier and least squares method. Its
-
A151036-500gProduct Introduction Aminoguanidine hydrochloride has been reported in a study as inhibitor of animal nitric oxide (NO)-synthase. Crystal structure of aminoguanidine hydrochloride has been investigated by Fourier and least squares method. Its
-
A129574-100gAn inhibitor of 1,4-dihydropyridine binding to L-type Ca2+ channels.